Delivery Order SPE2DR25D2104-SPE2DR26F3UBE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10 capsules. This competitively awarded, non-set-aside contract has a ceiling value of $2,036.45 with a firm fixed-price structure and an ultimate completion date of January 9, 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10s). The contract is valued at $14,926.77 with a completion date of January 8, 2026, and is structured as a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,246.76 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packs of 10 on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,540.43 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules (100-count packaging) on January 13, 2026, with an ultimate completion date of January 14, 2026. This is a firm fixed-price contract with no set-aside designation, indicating open competition. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and pharmaceutical...
- The Defense Logistics Agency awarded a $5,694.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on December 2, 2025, with completion due by December 3, 2025. This competitive award, which received no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules (100-count packages) with a ceiling value of $1,890.00. This firm fixed-price delivery order is set to be completed by December 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a competitive award with no set-aside designation, issued under...
- The Defense Logistics Agency awarded a $7,491.60 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packs of 10. This is a firm fixed-price contract with performance completion targeted for December 9, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a delivery order valued at $8,776.40 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging on January 22, 2026, with completion scheduled for January 23, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,336.25 to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is scheduled for completion by January 9, 2026, and performance will be executed from the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,388.84 to supply Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The order was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of December 19, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3UBEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s, with a ceiling value of $1,408.31. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of January 22, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Oseltamivir, an antiviral medication commonly used for influenza treatment and prophylaxis, represents the type of critical pharmaceutical commodity routinely procured through this contract vehicle to support military treatment facilities and defense health operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/20/26 |